Board of Scientific Counselors, National Center for Injury Prevention and Control, (BSC, NCIPC), 77352 [2015-31367]

Download as PDF 77352 Federal Register / Vol. 80, No. 239 / Monday, December 14, 2015 / Notices reviewers following their review of a draft of the full Guideline, along with a summary of comments received and CDC responses. Dated: December 9, 2015. Veronica Kennedy, Acting Executive Secretary, Centers for Disease Control and Prevention. [FR Doc. 2015–31375 Filed 12–11–15; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention mstockstill on DSK4VPTVN1PROD with NOTICES Board of Scientific Counselors, National Center for Injury Prevention and Control, (BSC, NCIPC) In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces, the following meeting of the aforementioned committee: Time and Date: 9:00 a.m.–1:00 p.m., January 7, 2016 (OPEN). Place: Teleconference Dial-In Number: 1–888–395–7561, Participant Code: 3954121. Status: The meeting as designated above will be open to the public. Purpose: The Board will: (1) Conduct, encourage, cooperate with, and assist other appropriate public health authorities, scientific institutions, and scientists in the conduct of research, investigations, experiments, demonstrations, and studies relating to the causes, diagnosis, treatment, control, and prevention of physical and mental diseases, and other impairments; (2) assist States and their political subdivisions in preventing and suppressing communicable and noncommunicable diseases and other preventable conditions and in promoting health and well-being; and (3) conduct and assist in research and control activities related to injury. The Board of Scientific Counselors makes recommendations regarding policies, strategies, objectives, and priorities; and reviews progress toward injury prevention goals and provides evidence in injury prevention-related research and programs. The Board also provides advice on the appropriate balance of intramural and extramural research, the structure, progress and performance of intramural programs. The Board is designed to provide guidance on extramural scientific program matters, including the: (1) Review of extramural research concepts for funding opportunity VerDate Sep<11>2014 17:36 Dec 11, 2015 Jkt 238001 announcements; (2) conduct of Secondary Peer Review of extramural research grants, cooperative agreements, and contracts applications received in response to the funding opportunity announcements as it relates to the Center’s programmatic balance and mission; (3) submission of secondary review recommendations to the Center Director of applications to be considered for funding support; (4) review of research portfolios, and (5) review of program proposals. Matters for Discussion: The Board of Scientific Counselors will discuss the background for development of the CDC Guideline for Prescribing Opioids for Chronic Pain (Guideline) and the formation of the Prescribing Opioids for Chronic Pain Workgroup (Opioid Guideline Workgroup). We will be accepting public comments only related to the formation of the Opioid Guideline Workgroup. There will be 30 minutes allotted for public comments at the end of the session. All public comments will be limited to two-minutes per speaker. CDC is also publishing a related notice in today’s Federal Register announcing the opening of a public comment period on the Guideline itself. Individuals are given 30 days to provide comments on the Guideline. Please see instructions in that notice about providing comment. Agenda items are subject to change as priorities dictate. Contact Person for More Information: Arlene Greenspan, Dr. P.H, M.P.H., P.T., Associate Director for Science, NCIPC, CDC, 4770 Buford Highway NE., Mailstop F–63, Atlanta, Georgia 30341, Telephone (770) 488–4696. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2015–31367 Filed 12–11–15; 8:45 am] BILLING CODE 4163–18–P PO 00000 Frm 00039 Fmt 4703 Sfmt 4703 DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Medicare & Medicaid Services [Document Identifiers: CMS–R–282 and CMS–10597] Agency Information Collection Activities: Proposed Collection; Comment Request Centers for Medicare & Medicaid Services, HHS. ACTION: Notice. AGENCY: The Centers for Medicare & Medicaid Services (CMS) is announcing an opportunity for the public to comment on CMS’ intention to collect information from the public. Under the Paperwork Reduction Act of 1995 (the PRA), federal agencies are required to publish notice in the Federal Register concerning each proposed collection of information (including each proposed extension or reinstatement of an existing collection of information) and to allow 60 days for public comment on the proposed action. Interested persons are invited to send comments regarding our burden estimates or any other aspect of this collection of information, including any of the following subjects: (1) The necessity and utility of the proposed information collection for the proper performance of the agency’s functions; (2) the accuracy of the estimated burden; (3) ways to enhance the quality, utility, and clarity of the information to be collected; and (4) the use of automated collection techniques or other forms of information technology to minimize the information collection burden. SUMMARY: Comments must be received by February 12, 2016. ADDRESSES: When commenting, please reference the document identifier or OMB control number. To be assured consideration, comments and recommendations must be submitted in any one of the following ways: 1. Electronically. You may send your comments electronically to https:// www.regulations.gov. Follow the instructions for ‘‘Comment or Submission’’ or ‘‘More Search Options’’ to find the information collection document(s) that are accepting comments. 2. By regular mail. You may mail written comments to the following address: CMS, Office of Strategic Operations and Regulatory Affairs, Division of Regulations Development, Attention: Document Identifier/OMB Control Number ___, Room C4–26–05, DATES: E:\FR\FM\14DEN1.SGM 14DEN1

Agencies

[Federal Register Volume 80, Number 239 (Monday, December 14, 2015)]
[Notices]
[Page 77352]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-31367]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Board of Scientific Counselors, National Center for Injury 
Prevention and Control, (BSC, NCIPC)

    In accordance with Section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces, the following meeting of the aforementioned 
committee:
    Time and Date: 9:00 a.m.-1:00 p.m., January 7, 2016 (OPEN).
    Place: Teleconference Dial-In Number: 1-888-395-7561, Participant 
Code: 3954121.
    Status: The meeting as designated above will be open to the public.
    Purpose: The Board will: (1) Conduct, encourage, cooperate with, 
and assist other appropriate public health authorities, scientific 
institutions, and scientists in the conduct of research, 
investigations, experiments, demonstrations, and studies relating to 
the causes, diagnosis, treatment, control, and prevention of physical 
and mental diseases, and other impairments; (2) assist States and their 
political subdivisions in preventing and suppressing communicable and 
non-communicable diseases and other preventable conditions and in 
promoting health and well-being; and (3) conduct and assist in research 
and control activities related to injury.
    The Board of Scientific Counselors makes recommendations regarding 
policies, strategies, objectives, and priorities; and reviews progress 
toward injury prevention goals and provides evidence in injury 
prevention-related research and programs. The Board also provides 
advice on the appropriate balance of intramural and extramural 
research, the structure, progress and performance of intramural 
programs. The Board is designed to provide guidance on extramural 
scientific program matters, including the: (1) Review of extramural 
research concepts for funding opportunity announcements; (2) conduct of 
Secondary Peer Review of extramural research grants, cooperative 
agreements, and contracts applications received in response to the 
funding opportunity announcements as it relates to the Center's 
programmatic balance and mission; (3) submission of secondary review 
recommendations to the Center Director of applications to be considered 
for funding support; (4) review of research portfolios, and (5) review 
of program proposals.
    Matters for Discussion: The Board of Scientific Counselors will 
discuss the background for development of the CDC Guideline for 
Prescribing Opioids for Chronic Pain (Guideline) and the formation of 
the Prescribing Opioids for Chronic Pain Workgroup (Opioid Guideline 
Workgroup). We will be accepting public comments only related to the 
formation of the Opioid Guideline Workgroup. There will be 30 minutes 
allotted for public comments at the end of the session. All public 
comments will be limited to two-minutes per speaker.
    CDC is also publishing a related notice in today's Federal Register 
announcing the opening of a public comment period on the Guideline 
itself. Individuals are given 30 days to provide comments on the 
Guideline. Please see instructions in that notice about providing 
comment.
    Agenda items are subject to change as priorities dictate.
    Contact Person for More Information: Arlene Greenspan, Dr. P.H, 
M.P.H., P.T., Associate Director for Science, NCIPC, CDC, 4770 Buford 
Highway NE., Mailstop F-63, Atlanta, Georgia 30341, Telephone (770) 
488-4696.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining to 
announcements of meetings and other committee management activities, 
for both the Centers for Disease Control and Prevention and the Agency 
for Toxic Substances and Disease Registry.

Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
[FR Doc. 2015-31367 Filed 12-11-15; 8:45 am]
 BILLING CODE 4163-18-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.